Awardee OrganizationKAISER FOUNDATION HEALTH PLAN OF WASHINGTON
Description
Abstract Text
DESCRIPTION (provided by applicant): Since 1987, the UW (University of Washington)and GHC/CHS(Group Health Cooperative/Center for Health Studies) Alzheimer's Disease Patient Registry (ADPR) and Adult Changes in Thought (ACT) Study has established itself as a model incident case-finding registry as well as developed a prospective cohort of over 3,300 persons, initially without dementia. The ACT inception cohort, established 1994-96, was designed to detect new cases of dementia (especially AD), and to collect prospective data to identify potentially modifiable risk factors for AD and related conditions. To date, 309 persons have developed dementia, with an additional 291 cases projected in the near future, for a total of 600 cases.
The combination of prospectively collected data over time (baseline & biennial follow-ups), plus
comprehensive medical and pharmacy historic records for 10 to 20 years (median GHC membership is
19 years prior to enrollment), creates unparalleled opportunity for analyses using the ACT cohort data in the coming 5 years. The specific aims for this next cycle are:
1. To undertake innovative analyses of the pharmacoepidemiology of dementia and AD; specifically
antihypertensive agents, post-menopausal hormone replacement therapy, HMC-CoA reductase
inhibitors ("statins") and other antihyperlipidemic agents, non-steroidal anti-inflammatory drugs
(NSAIDs), histamine H2 receptor antagonists, and antioxidant vitamins.
2. To evaluate other potential risk factors for AD and dementia, with emphasis on vascular risk factors,
capitalizing on the rich ACT and GHC data sources to investigate: blood pressure, plasma lipids,
exercise history, obesity, diabetes, and tobacco use.
3. To continue to serve as a vital source of long-term, comprehensive data and well-characterized research subjects for other investigators.
The results of these studies will be invaluable to the development and testing of strategies to reduce the risk of AD and related conditions, and to reduce the burden of cognitive decline in the growing population of older persons.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Alzheimer's diseasebrain disorder diagnosisclinical researchcooperative studydisease /disorder proneness /riskdrug adverse effecthuman population geneticshuman subjectlongitudinal human studymental health epidemiologymental health information systemneuropsychological testspathologic processpatient /disease registryracial /ethnic difference
No Sub Projects information available for 5U01AG006781-19
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01AG006781-19
Patents
No Patents information available for 5U01AG006781-19
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01AG006781-19
Clinical Studies
No Clinical Studies information available for 5U01AG006781-19
News and More
Related News Releases
No news release information available for 5U01AG006781-19
History
No Historical information available for 5U01AG006781-19
Similar Projects
No Similar Projects information available for 5U01AG006781-19